Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan · Delayed Price · Currency is TWD 79.50
0.00 (0.00%)
Mar 5, 2026, 1:30 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 12.51 billion as of March 5, 2026. Its market cap has increased by 19.38% in one year.
Market Cap
12.51B
Enterprise Value
9.94B
Revenue
1.62B
Ranking
n/a
PE Ratio
17.54
Stock Price
79.50
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 12.51B, an increase of 50.35%. That is a compound annual growth rate of 4.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 12.51B | -7.56% |
| Dec 31, 2025 | 13.53B | 27.93% |
| Dec 31, 2024 | 10.58B | -59.15% |
| Dec 29, 2023 | 25.89B | 61.07% |
| Dec 30, 2022 | 16.07B | 90.20% |
| Dec 30, 2021 | 8.45B | 199.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TTY Biopharm Company | 20.74B |
| Grape King Bio | 17.70B |
| ScinoPharm Taiwan | 15.85B |
| Synmosa Biopharma | 15.80B |
| YungShin Global Holding | 14.44B |
| Foresee Pharmaceuticals | 12.63B |
| Standard Chemical & Pharmaceutical | 11.44B |
| Alar Pharmaceuticals | 11.16B |